Eurazeo to sell Seqens stake to SK Capital et al.

  • by


Eurazeo has entered into exclusive negotiations to sell its stake in pharmaceutical and specialty ingredients producer Seqens to SK Capital, as well the company’s existing shareholders, which include Ardian.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *